The chicken miR-150 targets the avian orthologue of the functional zebrafish MYB 3'UTR target site.
BACKGROUND
The c-myb proto-oncogene is the founding member of a family of transcription factors involved principally in haematopoiesis, in diverse organisms, from zebrafish to mammals. Its deregulation has been implicated in human leukaemogenesis and other cancers. The expression of c-myb is tightly regulated by post-transcriptional mechanisms involving microRNAs. MicroRNAs are small, highly conserved non-coding RNAs that inhibit translation and decrease mRNA stability by binding to regulatory motifs mostly located in the 3'UTR of target mRNAs conserved throughout evolution. MYB is an evolutionarily conserved miR-150 target experimentally validated in mice, humans and zebrafish. However, the functional miR-150 sites of humans and mice are orthologous, whereas that of zebrafish is different.


RESULTS
We identified the avian mature miRNA-150-5P, Gallus gallus gga-miR-150 from chicken leukocyte small-RNA libraries and showed that, as expected, the gga-miR-150 sequence was highly conserved, including the seed region sequence present in the other miR-150 sequences listed in miRBase. Reporter assays showed that gga-miR-150 acted on the avian MYB 3'UTR and identified the avian MYB target site involved in gga-miR-150 binding. A comparative in silico analysis of the miR-150 target sites of MYB 3'UTRs from different species led to the identification of a single set of putative target sites in amphibians and zebrafish, whereas two sets of putative target sites were identified in chicken and mammals. However, only the target site present in the chicken MYB 3'UTR that was identical to that in zebrafish was functional, despite the additional presence of mammalian target sites in chicken. This specific miR-150 site usage was not cell-type specific and persisted when the chicken c-myb 3'UTR was used in the cell system to identify mammalian target sites, showing that this miR-150 target site usage was intrinsic to the chicken c-myb 3'UTR.


CONCLUSIONS
Our study of the avian MYB/gga-miR-150 interaction shows a conservation of miR-150 target site functionality between chicken and zebrafish that does not extend to mammals.
Guillon-Munos
Audrey
A
Université François Rabelais, Equipe Transcription, Lymphome Viro-induit, UFR Sciences et Techniques, Parc de Grandmont, F-37200 Tours, France.
Dambrine
Ginette
G
Richerioux
Nicolas
N
Coupeau
Damien
D
Muylkens
Benoît
B
Rasschaert
Denis
D
D020413:3' Untranslated Regions; D000818:Animals; D001483:Base Sequence; D002645:Chickens / Q000235:genetics*; D005786:Gene Expression Regulation; D017930:Genes, Reporter; D020570:Genes, myb; D006801:Humans; D051379:Mice; D035683:MicroRNAs / Q000235:genetics* / Q000378:metabolism; D008969:Molecular Sequence Data; D000090063:Proto-Oncogene Mas; D020598:Proto-Oncogene Proteins c-myb / Q000235:genetics* / Q000378:metabolism; D015027:Zebrafish / Q000235:genetics*
D020413:3' Untranslated Regions; C000715470:MAS1 protein, human; D035683:MicroRNAs; D000090063:Proto-Oncogene Mas; D020598:Proto-Oncogene Proteins c-myb
Immunogenetics. 2009 Jan;61(1):55-70
19009289
Immunity. 2005 Sep;23(3):275-86
16169500
Exp Hematol. 2008 Dec;36(12):1585-92
18814950
BMC Genomics. 2008 Apr 22;9:185
18430245
Genes Chromosomes Cancer. 2006 Dec;45(12):1143-54
16977606
J Gen Virol. 2009 May;90(Pt 5):1164-1171
19264608
Hybridoma. 1986 Winter;5(4):319-28
2433209
Nature. 2005 Feb 17;433(7027):769-73
15685193
Blood. 2007 Aug 15;110(4):1251-61
17452517
Cell. 2007 Oct 5;131(1):146-59
17923094
Oncogene. 1997 Apr 10;14(14):1715-23
9135073
Dev Cell. 2008 Jun;14(6):843-53
18539114
Growth Factors. 2005 Dec;23(4):253-61
16338788
Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7080-5
17438277
Mol Biol Evol. 2008 Oct;25(10):2189-98
18667440
Nat Genet. 2007 May;39(5):593-5
17435759
EMBO J. 1994 Dec 15;13(24):5994-6005
7813437
EMBO J. 1996 Jun 3;15(11):2771-80
8654374
Genome Res. 2009 Jan;19(1):92-105
18955434
Nucleic Acids Res. 1988 Dec 9;16(23):11075-89
3060855
PLoS Biol. 2004 Nov;2(11):e363
15502875
Mol Cell. 2007 Jul 6;27(1):91-105
17612493
Oncogene. 1999 May 13;18(19):3017-33
10378697
Genome Res. 2008 Jun;18(6):957-64
18469162
Trends Genet. 1997 Feb;13(2):67-73
9055608
J Gen Virol. 2009 Jul;90(Pt 7):1551-1559
19297609
Virology. 1998 Sep 1;248(2):295-304
9721238
Mol Cell Biol. 1986 Feb;6(2):380-92
3023843
Methods Mol Biol. 2006;342:129-38
16957372
Nat Rev Cancer. 2008 Jul;8(7):523-34
18574464
Cell. 1982 Dec;31(2 Pt 1):453-63
6297766
Nature. 2004 Dec 9;432(7018):695-716
15592404
Oncogene. 1990 Jan;5(1):131-5
2181374
J Virol. 1983 Apr;46(1):212-20
6298458
FEBS Lett. 2009 May 6;583(9):1422-6
19328789
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18740-4
19841262
Virology. 2007 Sep 1;365(2):464-72
17493657
Poult Sci. 2008 Nov;87(11):2335-43
18931185
J Cell Physiol. 1999 Jun;179(3):245-50
10228942
Cell. 2009 Jan 23;136(2):215-33
19167326
EMBO J. 2009 May 20;28(10):1492-504
19360001
Cell. 2005 Jan 14;120(1):15-20
15652477
Nat Rev Mol Cell Biol. 2009 Feb;10(2):141-8
19145236
Endocrinology. 2009 Apr;150(4):1597-606
19036881
Development. 2007 Dec;134(23):4147-56
17959717
PLoS Biol. 2005 Mar;3(3):e85
15723116
J Virol. 2003 May;77(10):5985-96
12719590
Eur J Haematol. 2008 Oct;81(4):304-10
18573170
Gene Amplif Anal. 1986;4:73-98
3333362
Development. 2008 May;135(10):1853-62
18417622
Genes Dev. 1996 Mar 1;10(5):528-40
8598284
Science. 1987 Sep 18;237(4821):1473-6
3498214
Lab Invest. 2009 Jun;89(6):708-16
19349957
Gene. 2008 Jul 15;418(1-2):34-40
18511220
J Biol Chem. 2009 Sep 18;284(38):25791-803
19608742
J Virol. 2008 Apr;82(8):4007-15
18256158
Cell. 2004 Jan 23;116(2):281-97
14744438
Cell. 2005 Aug 26;122(4):553-63
16122423
Nature. 2005 Mar 17;434(7031):338-45
15735639
Biken J. 1974 Sep;17(3):105-16
4616680
J Virol. 2009 Jan;83(1):489-92
18945769
Nature. 1988 Oct 27;335(6193):835-7
3185713